<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04111354</url>
  </required_header>
  <id_info>
    <org_study_id>Early mobilization 14-3-2019</org_study_id>
    <nct_id>NCT04111354</nct_id>
  </id_info>
  <brief_title>Early Mobilization After Pacemaker Implantation.</brief_title>
  <acronym>EMAPI</acronym>
  <official_title>Early Mobilization After Pacemaker Implantation.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Charles University, Czech Republic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Charles University, Czech Republic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Permanent pacemaker implantation is one of the most common arrhythmological procedure. This
      procedure is usually accompanied by a minimum of 2-3 days hospitalization, with
      immobilization of patients (supine) for 16-24 hours. The optimal duration of patientÂ´s
      immobilization is not determined. There is also no recommendation from individual
      manufacturers of pacemakers for the duration of immobilization after pacemaker implantation.
      The length of immobilization is based rather on the tradition established at the time of
      using electrodes with passive fixation. The aim of our prospective, randomized study (EMAPI)
      is to compare the safety of short-term (4-hours) immobilization with long-term (16-24 hours)
      immobilization after primary pacemaker implantation. Septal position will be used for right
      ventricular electrode.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 28, 2019</start_date>
  <completion_date type="Anticipated">March 2021</completion_date>
  <primary_completion_date type="Anticipated">March 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Composite endpoint of incidence of adverse events from secondary outcomes depending on the length of immobilization (early vs. late).</measure>
    <time_frame>6 months</time_frame>
    <description>Comparsion of incidence of dislodgement of atrial electrode, dislodgement of ventricular electrode in septal position, hematoma surgically treated or requiring blood transfusions, pneumothorax, pocket infection, others complications</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of atrial lead dislodgement.</measure>
    <time_frame>6 months</time_frame>
    <description>comparsion of early vs. late mobilization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of ventricular lead dislodgement.</measure>
    <time_frame>6 months</time_frame>
    <description>comparsion of early vs. late mobilization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of hematoma (surgically treated or requiring blood transfusions.)</measure>
    <time_frame>6 months</time_frame>
    <description>comparsion of early vs. late mobilization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of pneumothorax.</measure>
    <time_frame>24 hours</time_frame>
    <description>comparsion of early vs. late mobilization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of pocket infection.</measure>
    <time_frame>6 months</time_frame>
    <description>comparsion of early vs. late mobilization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of others complications.</measure>
    <time_frame>6 months</time_frame>
    <description>comparsion of early vs. late mobilization, (mechanical, extracardiac complication etc.)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Pacemaker Complication</condition>
  <condition>Mobilization</condition>
  <arm_group>
    <arm_group_label>Short-term (4-hours) immobilization.</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Short-term (4-hours) immobilization after primary pacemaker implantation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Long-term (16-24 hours) immobilization.</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Long-term (16-24 hours) immobilization after primary pacemaker implantation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Pacemaker implantation</intervention_name>
    <description>Pacemaker implantation</description>
    <arm_group_label>Long-term (16-24 hours) immobilization.</arm_group_label>
    <arm_group_label>Short-term (4-hours) immobilization.</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. 18 years and older.

          2. Indication for permanent pacemaker implantation.

          3. Mobile and compliant patient.

          4. Willing and able to give written informed consent.

        Exclusion Criteria:

          1. Imobile and noncompliant patient.

          2. Indication of CRT implantation.

          3. Upgrade or revision of implanted devise.

          4. Contraindications to pacemaker implantation.

          5. Gravidity.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Jiri Smid, Cardiology department, University Hospital and Faculty of Medicine in Pilsen, Charles University, Czech Republic</name>
      <address>
        <city>Plzen</city>
        <zip>32300</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jiri Smid</last_name>
      <phone>+420377103170</phone>
      <email>smidj@fnplzen.cz</email>
    </contact>
  </location>
  <location_countries>
    <country>Czechia</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>September 6, 2019</study_first_submitted>
  <study_first_submitted_qc>September 30, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 1, 2019</study_first_posted>
  <last_update_submitted>September 30, 2019</last_update_submitted>
  <last_update_submitted_qc>September 30, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 1, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Charles University, Czech Republic</investigator_affiliation>
    <investigator_full_name>Jiri Smid</investigator_full_name>
    <investigator_title>M.D.</investigator_title>
  </responsible_party>
  <keyword>pacemaker</keyword>
  <keyword>implantation</keyword>
  <keyword>mobilization</keyword>
  <keyword>complication</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

